Microba Life Sciences Ltd
ASX:MAP
Wall Street
Price Targets
MAP Price Targets Summary
Microba Life Sciences Ltd
According to Wall Street analysts, the average 1-year price target for MAP is 0.39 AUD with a low forecast of 0.35 AUD and a high forecast of 0.46 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MAP's stock price target?
Price Target
0.39
AUD
According to Wall Street analysts, the average 1-year price target for MAP is 0.39 AUD with a low forecast of 0.35 AUD and a high forecast of 0.46 AUD.
What is Microba Life Sciences Ltd's Revenue forecast?
Projected CAGR
86%
For the last 3 years the compound annual growth rate for Microba Life Sciences Ltd's revenue is 23%. The projected CAGR for the next 3 years is 86%.